Aiomic is one of 128 startups selected from a pool of 1,300 applications for the program.

We received the incredible news that we have been awarded a significant Innobooster grant to support the process of bringing our first product to market in the US and piloting it with some of the top US hospitals.

Aiomic has been featured in none other than Science Magazine! It's not every day that our journey and commitment to leveraging AI for improving postoperative care gets showcased on such a revered platform.

Aiomic is Texas-bound! We're thrilled to share that we have been selected to participate in a 6-month accelerator program at the renowned Texas Medical Center (TMC) in Houston, USA...

We're thrilled to announce that Aiomic has been featured in BioWorld MedTech for securing €1.3 million in funding from Denmark's Bioinnovation Institute (BII).

We are excited to announce that we have secured 10 million Danish Kroner (DKK) in funding through convertible loans to further develop and commercialize our platform, Aiomic360.